Preventing unwanted pregnancies and protecting moms and babies since 1980
- With COVID-19 threatening to stall many essential services, Jhpiego supported rural health units to continue to provide services for sexual and reproductive health and rights, in part by procuring progestin-only subdermal implants (PSIs) and condoms, as well as personal protective equipment for health service providers conducting house-to-house visits to distribute the commodities. As of 30 June 2023, almost 40,000 packs of condoms were dispensed and almost 4,500 PSIs were inserted for clients who wanted them.
- The National Reproductive Health/Family Planning Guidelines, which Jhpiego helped develop, are still being used by family planning providers to offer standardized services to clients across the Philippines.
- Since the start of the Sexual Health and Empowerment (SHE) project, it has reached almost 6,800 women, as well as 195 men, 134 girls and 80 boys through family planning outreach and practicum service provision during training of health providers. The project also helped refurbish 24 health facilities to be adolescent-friendly.
- The SHE project provided Gender Transformation for Health training to 435 service providers (78% of which are women) for gender-responsive and youth-friendly service delivery. Based on assessments using the Gender Service Delivery Standards Tool, 17 out of 20 assessed facilities met at least 80% of standards for youth-friendly and gender-sensitive services.
Our Work in Philippines
Sexual Health and Empowerment: Women’s Voice and Leadership
This project, led by Oxfam Canada and funded by Global Affairs Canada, seeks to improve sexual and reproductive health and rights (SRHR) for women and girls in six underserved, conflict-affected and disadvantaged regions of Philippines. To reach this goal, the project is providing the target population with culturally- and gender-sensitive sexual and reproductive health programs and improving the effectiveness of women’s rights organizations to advance SRHR and prevent gender-based violence (GBV). As a technical partner, Jhpiego is improving the capacity of the public and private health system to provide comprehensive and gender-responsive SRHR information and services. This includes: training health service providers, enhancing youth-friendly and gender-responsive health facilities to provide comprehensive SRHR services, and enhancing the management and coordination for SRHR and GBV services.
Scale Up Cervical Cancer Elimination with Secondary Prevention Strategy (SUCCESS)
Unitaid is funding a consortium, led by Expertise France, that seeks to eliminate cervical cancer in Burkina Faso, Côte d’Ivoire, Guatemala and the Philippines through secondary prevention (i.e., detecting disease early to slow or halt its progress). The three-year SUCCESS project is designed to shift the countries from a largely opportunistic cervical cancer screening model to a systematic approach centered on innovations related to: 1) reinforced and simplified cervical cancer screening through the introduction of human papilloma virus (HPV) testing with self-collection sampling; 2) secondary prevention of cervical cancer including use of efficient methods for treatment of cervical precancerous lesions such as thermal ablation; and 3) intensified dissemination of information on cervical cancer and new preventive technologies. In so doing, SUCCESS aims to support countries to “leapfrog” to a state-of-the-art services model recommended by the World Health Organization. As the implementing partner of the consortium, Jhpiego is integrating and expanding cervical cancer prevention and treatment services into both new and existing platforms, relying on our established relationships with governments and stakeholders in all four countries. Through demand-generation and community engagement activities, the project plans to screen a total of 185,000 women, a significant proportion of whom will be women living with HIV. In the Philippines, Jhpiego is increasing the reach and potential impact of SUCCESS project activities with supplemental funding from Boeing and Roche.
Improving the Quality of Maternal Health Care in Health Facilities in the Philippines
The purpose of the project is to reduce maternal mortality by improving the quality of maternal health care within networked facilities in Sorsogon Province. To achieve this, Jhpiego is operationalizing quality systems for maternal health services in 18 public and private health facilities in one district, and establishing collaborative, effective and efficient referral networks among those health facilities to serve as models for other districts and provinces. The project team convenes leadership and staff in each facility to reach consensus on a facility-wide vision for quality improvement, generating a shared vision to nurture a culture of respect and quality. At each health facility, the project team provides technical assistance to strengthen emergency response and build capacity in meaningful data use for maternal health. In close collaboration with local government unit partners, Jhpiego is establishing referral networks in one district. This award is a joint investment from MSD Philippines and MSD for Mothers, under their Global Grant Program.
Support to the HPV Vaccine Acceleration Program Partners Initiative (HAPPI) Consortium
The human papillomavirus (HPV) vaccine is one of the most effective ways to prevent cervical cancer and other HPV-related diseases, yet there is still disproportionate access to it, specifically among girls and adolescents in low- and middle-income countries. The HAPPI Consortium, funded by the Bill & Melinda Gates Foundation, was launched to increase and sustain equity and program quality, and accelerate coverage of HPV vaccination. John Snow, Inc. and HAPPI Consortium partners Jhpiego, the Clinton Health Access Initiative, International Vaccine Access Center and PATH are focusing on enabling evidence-based policy decisions, enhancing and sustaining equity, improving program quality, providing direct technical assistance in selected countries and monitoring, evaluating and learning to build on the evidence base. Specifically, Jhpiego is supporting the HAPPI/HPV Accelerator-Phase 1 Project to facilitate global coordination and provide HPV vaccine support in several countries, including the Philippines.